Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lingjun Chen
Observed names:
L P Chen,
Liangquan Chen
Institution:
Inner Mongolia People's Hospital
Observed institutions:
Ningbo University,
Chinese Academy of Sciences,
Shanghai Institute of Materia Medica,
Inner Mongolia People's Hospital,
Third Affiliated Hospital of Sun Yat-sen University,
University of Chinese Academy of Sciences
show all 6
ORCID:
0000-0002-5792-1930
Observed ORCID:
0000-0002-5792-1930
OpenAlex ID:
A5033706175
PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
2023
·
Qi Zhou
, Leijia Li
, et al.
·
Cancer Research
·
79
SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways
2016
·
T T Zhou
, L L Quan
, et al.
·
Cell Death and Disease
·
35
PDF
[Non-small cell lung cancer-derived exosomal circular RNA circEZH2 activates fibroblasts by regulating the miR-495-3p / TPD52 axis and NF-κB pathway].
2024
·
J Xing
, L P Chen
, et al.
·
PubMed
·
3
Construction of EpCAM overexpression and knockdown vectors and their implications in colorectal cancer research
2025
·
Bingping Wang
, Jinkai Duan
, et al.
·
Frontiers in Genome Editing
·
1
PDF
Construction of the pCHD-21X19EpCAM-CAR lentiviral vector and generation of CAR-engineered natural killer cells from human PBMCs
2026
·
Bingping Wang
, Jinkai Duan
, et al.
·
European journal of medical research
Psychological triggers of cancer-associated hypercoagulability: A case study on lymph node metastasis in gastric cancer
2025
·
Hao Zhang
, ChunYang Wang
, et al.
·
Psycho-Oncologie
PDF
Supplemental Table from PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
2025
·
Qi Zhou
, Leijia Li
, et al.
Supplemental Methods and Materials from PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
2025
·
Qi Zhou
, Leijia Li
, et al.
Supplementary Figures from PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
2025
·
Qi Zhou
, Leijia Li
, et al.
Supplemental Methods and Materials from PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression
2024
·
Qi Zhou
, Leijia Li
, et al.
Supplementary Figures from PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression
2024
·
Qi Zhou
, Leijia Li
, et al.
Supplemental Table from PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression
2024
·
Qi Zhou
, Leijia Li
, et al.
Supplementary Figures from PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression
2024
·
Qi Zhou
, Leijia Li
, et al.
Supplemental Table from PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression
2024
·
Qi Zhou
, Leijia Li
, et al.
Supplemental Table from PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
2023
·
Qi Zhou
, Leijia Li
, et al.
Supplemental Methods and Materials from PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
2023
·
Qi Zhou
, Leijia Li
, et al.
Supplementary Figures from PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
2023
·
Qi Zhou
, Leijia Li
, et al.
Data from PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
2023
·
Qi Zhou
, Leijia Li
, et al.
Supplemental Table from PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
2023
·
Qi Zhou
, Leijia Li
, et al.
Data from PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
2023
·
Qi Zhou
, Leijia Li
, et al.
Immuno-deficiency acquired during carcinogenesis: a mechanism facilitating cancer development.
1987
·
Y H Zang
, S R Zhang
, et al.
·
PubMed
Show more works
View as search
Works count:
21
Citation count:
118
H-index:
3
I10-index:
2
Year
Topic
Type
